{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:39:35Z","timestamp":1789195175191,"version":"build-2803163510"},"reference-count":50,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","license":[{"start":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T00:00:00Z","timestamp":1741305600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"the Key R&D Plan of Qingxiu District Nanning","award":["NO.2020056"],"award-info":[{"award-number":["NO.2020056"]}]},{"name":"the Joint Project on Regional High-Incidence Diseases Research of Guangxi Natural Science Foundation under Grant","award":["No.2023JJD140130"],"award-info":[{"award-number":["No.2023JJD140130"]}]},{"name":"the Key Laboratory of early Prevention & Treatment for regional High Frequency Tumor (Guangxi Medical University)-Ministry of Education","award":["GKE-ZZ202213"],"award-info":[{"award-number":["GKE-ZZ202213"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82060434"],"award-info":[{"award-number":["82060434"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["nos.82360465"],"award-info":[{"award-number":["nos.82360465"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,3,7]]},"abstract":"<jats:p>Asymptomatic gallbladder and biliary tract calculus may make into symptomatic disease or bring anxiety for patients. The formation of gallstones was associated with genetic risk factors and metabolic abnormalities. Genome-wide association studies (GWAS) data of 1400 plasma metabolites (PMs) and 91 circulating inflammatory cytokines (CICs) were obtained from the GWAS catalog, while the GWAS data of calculus of gallbladder without cholecystitis and calculus of bile duct without cholangitis or cholecystitis were retrieved from the IEU OpenGWAS project. The causalities from PMs or CICs to asymptomatic bile duct or cholecyst calculus were explored by 2-sample Mendelian randomization (MR) analysis. Furthermore, the MR analyses were implemented from the identified PMs to CICs. Following the false discovery rate adjustment, the significant causalities, including 6 CICs and 5 PMs on asymptomatic biliary stone and 5 CICs and 48 PMs on asymptomatic gallstone, were identified. Fibroblast growth factor 19 (FGF-19) and aspartate\/mannose ratio were the common protective factors of asymptomatic biliary tract calculus, while Monocyte chemoattractant protein 2 (CCL-2) may serve as a disease-promoting agent. Moreover, Bilirubin degradation product, C17H18N2O4 (1) levels, and Bilirubin (Z,Z)\/etiocholanolone glucuronide ratio were associated with FGF-19 level, while aspartate\/mannose ratio was related to TNF-related apoptosis-inducing ligand level. Based on MR analysis, we identified the multiple PMs and CICs, especially FGF-19, which may affect the formation of gallbladder and biliary tract calculus. Moreover, the partial CICs could be the downstream mediator of PMs related to asymptomatic gallbladder and biliary tract calculus. These results contributed to supporting previous studies and provided evidence for disease prevention or management.<\/jats:p>","DOI":"10.1097\/md.0000000000041745","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T00:43:29Z","timestamp":1743209009000},"page":"e41745","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["The mediating role of circulating inflammatory cytokines in causal associations between plasma metabolites and asymptomatic bile duct and cholecyst calculus: A Mendelian randomization study"],"prefix":"10.1097","volume":"104","author":[{"given":"Shayong","family":"Peng","sequence":"first","affiliation":[{"name":"Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, P.R. China"},{"name":"Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, Nanning, P.R. China"},{"name":"Key Laboratory of High-Incidence-Tumor Prevention and Treatment (Guangxi Medical University), Ministry of Education, Nanning, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongguang","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, P.R. China"},{"name":"Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, Nanning, P.R. China"},{"name":"Key Laboratory of High-Incidence-Tumor Prevention and Treatment (Guangxi Medical University), Ministry of Education, Nanning, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huasheng","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, P.R. China"},{"name":"Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, Nanning, P.R. China"},{"name":"Key Laboratory of High-Incidence-Tumor Prevention and Treatment (Guangxi Medical University), Ministry of Education, Nanning, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenlu","family":"Lan","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, P.R. China"},{"name":"Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, Nanning, P.R. China"},{"name":"Key Laboratory of High-Incidence-Tumor Prevention and Treatment (Guangxi Medical University), Ministry of Education, Nanning, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiming","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, P.R. China"},{"name":"Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, Nanning, P.R. China"},{"name":"Key Laboratory of High-Incidence-Tumor Prevention and Treatment (Guangxi Medical University), Ministry of Education, Nanning, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangzhi","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, P.R. China"},{"name":"Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, Nanning, P.R. China"},{"name":"Key Laboratory of High-Incidence-Tumor Prevention and Treatment (Guangxi Medical University), Ministry of Education, Nanning, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6133-7078","authenticated-orcid":false,"given":"Tao","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, P.R. China"},{"name":"Guangxi Key Laboratory of Enhanced Recovery after Surgery for Gastrointestinal Cancer, Nanning, P.R. China"},{"name":"Key Laboratory of High-Incidence-Tumor Prevention and Treatment (Guangxi Medical University), Ministry of Education, Nanning, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250328","doi-asserted-by":"crossref","first-page":"16024","DOI":"10.1038\/nrdp.2016.24","article-title":"Gallstones.","volume":"2","author":"Lammert","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"R2-20250328","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3390\/biom12040550","article-title":"Factors influencing gallstone formation: a review of the literature.","volume":"12","author":"Sun","year":"2022","journal-title":"Biomolecules"},{"key":"R3-20250328","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/MOG.0000000000000423","article-title":"An update on the pathogenesis of cholesterol gallstone disease.","volume":"34","author":"Di Ciaula","year":"2018","journal-title":"Curr Opin Gastroenterol"},{"key":"R4-20250328","first-page":"148","article-title":"The treatment of gallstone disease.","volume":"117","author":"Gutt","year":"2020","journal-title":"Deutsches Arzteblatt Int"},{"issue":"Suppl","key":"R5-20250328","doi-asserted-by":"crossref","first-page":"S406","DOI":"10.1194\/jlr.R800075-JLR200","article-title":"Biliary lipids and cholesterol gallstone disease.","volume":"50","author":"Wang","year":"2009","journal-title":"J Lipid Res"},{"key":"R6-20250328","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0140-6736(06)69044-2","article-title":"Cholesterol gallstone disease.","volume":"368","author":"Portincasa","year":"2006","journal-title":"Lancet (London, England)"},{"key":"R7-20250328","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.suc.2018.12.003","article-title":"Bile metabolism and lithogenesis: an update.","volume":"99","author":"Dosch","year":"2019","journal-title":"Surg Clin North Am"},{"key":"R8-20250328","first-page":"521","article-title":"Novel insights into causal effects of serum lipids and lipid-modifying targets on cholelithiasis.","volume":"73","author":"Chen","year":"2024","journal-title":"Gut"},{"key":"R9-20250328","doi-asserted-by":"crossref","first-page":"1438170","DOI":"10.3389\/fnut.2024.1438170","article-title":"The link between serum cotinine levels and gallstones prevalence in adults: a cross-sectional analysis using NHANES data (2017-2020).","volume":"11","author":"Liu","year":"2024","journal-title":"Front Nutr"},{"key":"R10-20250328","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.cccn.2004.06.022","article-title":"Dietary antioxidant lack, impaired hepatic glutathione reserve, and cholesterol gallstones.","volume":"349","author":"Worthington","year":"2004","journal-title":"Clin Chim Acta"},{"key":"R11-20250328","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.immuni.2019.07.002","article-title":"Neutrophil extracellular traps initiate gallstone formation.","volume":"51","author":"Mu\u00f1oz","year":"2019","journal-title":"Immunity"},{"key":"R12-20250328","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/hep.26424","article-title":"Genotype-phenotype relationships in the low-phospholipid-associated cholelithiasis syndrome: a study of 156 consecutive patients.","volume":"58","author":"Poupon","year":"2013","journal-title":"Hepatology (Baltimore, Md)"},{"key":"R13-20250328","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3390\/genes13061047","article-title":"Genetic analysis of ABCB4 mutations and variants related to the pathogenesis and pathophysiology of low phospholipid-associated cholelithiasis.","volume":"13","author":"Wang","year":"2022","journal-title":"Genes"},{"key":"R14-20250328","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41467-021-27758-8","article-title":"Gut microbiota promotes cholesterol gallstone formation by modulating bile acid composition and biliary cholesterol secretion.","volume":"13","author":"Hu","year":"2022","journal-title":"Nat Commun"},{"key":"R15-20250328","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1080\/17474124.2018.1533812","article-title":"Role of the biliary microbiome in gallstone disease.","volume":"12","author":"Wang","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"R16-20250328","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12876-020-01195-1","article-title":"Intestinal flora imbalance affects bile acid metabolism and is associated with gallstone formation.","volume":"20","author":"Wang","year":"2020","journal-title":"BMC Gastroenterol"},{"key":"R17-20250328","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1186\/1471-2164-14-669","article-title":"Gut microbiota dysbiosis and bacterial community assembly associated with cholesterol gallstones in large-scale study.","volume":"14","author":"Wu","year":"2013","journal-title":"BMC Genomics"},{"key":"R18-20250328","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12876-017-0629-2","article-title":"Alteration of gut microbiota in association with cholesterol gallstone formation in mice.","volume":"17","author":"Wang","year":"2017","journal-title":"BMC Gastroenterol"},{"key":"R19-20250328","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12944-023-01989-8","article-title":"Associations of fatty acids with the risk of biliary tract calculus and inflammation: a Mendelian randomization study.","volume":"23","author":"Xie","year":"2024","journal-title":"Lipids Health Dis"},{"key":"R20-20250328","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41588-022-01270-1","article-title":"Genomic atlas of the plasma metabolome prioritizes metabolites implicated in human diseases.","volume":"55","author":"Chen","year":"2023","journal-title":"Nat Genet"},{"key":"R21-20250328","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41590-023-01588-w","article-title":"Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets.","volume":"24","author":"Zhao","year":"2023","journal-title":"Nat Immunol"},{"key":"R22-20250328","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using mendelian randomization: the STROBE-MR statement.","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"key":"R23-20250328","doi-asserted-by":"crossref","first-page":"10393","DOI":"10.1002\/cam4.5772","article-title":"Gut microbiota and risk of five common cancers: a univariable and multivariable Mendelian randomization study.","volume":"12","author":"Wei","year":"2023","journal-title":"Cancer Med"},{"key":"R24-20250328","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1111\/add.15767","article-title":"Genetic liability for prescription opioid use and risk of cardiovascular diseases: a multivariable Mendelian randomization study.","volume":"117","author":"Cai","year":"2022","journal-title":"Addiction (Abingdon, England)"},{"key":"R25-20250328","doi-asserted-by":"crossref","first-page":"1115014","DOI":"10.3389\/fmicb.2023.1115014","article-title":"Roles of gut microbiome in epilepsy risk: a Mendelian randomization study.","volume":"14","author":"Zeng","year":"2023","journal-title":"Front Microbiol"},{"key":"R26-20250328","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nmeth.1974","article-title":"The 1000 Genomes Project: data management and community access.","volume":"9","author":"Clarke","year":"2012","journal-title":"Nat Methods"},{"key":"R27-20250328","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: a tool set for whole-genome association and population-based linkage analyses.","volume":"81","author":"Purcell","year":"2007","journal-title":"Am J Hum Genet"},{"key":"R28-20250328","doi-asserted-by":"crossref","first-page":"1243811","DOI":"10.3389\/fmicb.2023.1243811","article-title":"Mendelian randomization supports causality between gut microbiota and chronic hepatitis B.","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Microbiol"},{"key":"R29-20250328","doi-asserted-by":"crossref","first-page":"1113334","DOI":"10.3389\/fmicb.2023.1113334","article-title":"Exploring the causal effects of the gut microbiome on serum lipid levels: a two-sample Mendelian randomization analysis.","volume":"14","author":"Guo","year":"2023","journal-title":"Front Microbiol"},{"key":"R30-20250328","doi-asserted-by":"crossref","first-page":"1359502","DOI":"10.3389\/fendo.2024.1359502","article-title":"Causal association of circulating metabolites with diabetic retinopathy: a bidirectional Mendelian randomization analysis.","volume":"15","author":"Li","year":"2024","journal-title":"Front Endocrinol"},{"key":"R31-20250328","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"R32-20250328","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41581-021-00454-y","article-title":"Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function.","volume":"17","author":"Brennan","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"R33-20250328","doi-asserted-by":"crossref","first-page":"155610","DOI":"10.1016\/j.metabol.2023.155610","article-title":"Glutaredoxin 1 regulates cholesterol metabolism and gallstone formation by influencing protein S-glutathionylation.","volume":"145","author":"Xia","year":"2023","journal-title":"Metab Clin Exp"},{"key":"R34-20250328","doi-asserted-by":"crossref","first-page":"1401420","DOI":"10.3389\/fpubh.2024.1401420","article-title":"Phthalate and gallstones: the mediation of insulin.","volume":"12","author":"Tang","year":"2024","journal-title":"Front Public Health"},{"key":"R35-20250328","doi-asserted-by":"crossref","first-page":"1336673","DOI":"10.3389\/fmicb.2024.1336673","article-title":"Gut microbiota, circulating metabolites, and gallstone disease: a Mendelian randomization study.","volume":"15","author":"Hu","year":"2024","journal-title":"Front Microbiol"},{"key":"R36-20250328","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1177\/2050640614527938","article-title":"Upregulation of hepatic bile acid synthesis via fibroblast growth factor 19 is defective in gallstone disease but functional in overweight individuals.","volume":"2","author":"Renner","year":"2014","journal-title":"United Eur Gastroenterol J"},{"key":"R37-20250328","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrgastro.2014.32","article-title":"Bile acid diarrhoea and FGF19: new views on diagnosis, pathogenesis and therapy.","volume":"11","author":"Walters","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R38-20250328","doi-asserted-by":"crossref","first-page":"154728","DOI":"10.1016\/j.metabol.2021.154728","article-title":"Glucagon-like peptide 1 analogue prevents cholesterol gallstone formation by modulating intestinal farnesoid X receptor activity.","volume":"118","author":"Zhang","year":"2021","journal-title":"Metab Clin Exp"},{"key":"R39-20250328","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1053\/j.gastro.2016.04.007","article-title":"Four susceptibility loci for gallstone disease identified in a meta-analysis of genome-wide association studies.","volume":"151","author":"Joshi","year":"2016","journal-title":"Gastroenterology"},{"key":"R40-20250328","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1002\/hep.31140","article-title":"Monocytes as potential mediators of pathogen-induced T-helper 17 differentiation in patients with primary sclerosing cholangitis (PSC).","volume":"72","author":"Kunzmann","year":"2020","journal-title":"Hepatology (Baltimore, Md)"},{"key":"R41-20250328","doi-asserted-by":"crossref","first-page":"6256","DOI":"10.1007\/s11033-013-2737-6","article-title":"Cytokine single nucleotide polymorphisms in patients\u2019 with gallstone: dose TGF-\u03b2 gene variants affect gallstone formation?","volume":"40","author":"Ebadi","year":"2013","journal-title":"Mol Biol Rep"},{"key":"R42-20250328","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/hep.510270304","article-title":"Time dependent changes in the concentration and type of bacterial sequences found in cholesterol gallstones.","volume":"27","author":"Swidsinski","year":"1998","journal-title":"Hepatology (Baltimore, Md)"},{"key":"R43-20250328","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1001\/jamainternmed.2013.6465","article-title":"Extreme bilirubin levels as a causal risk factor for symptomatic gallstone disease.","volume":"173","author":"Stender","year":"2013","journal-title":"JAMA Internal Med"},{"issue":"3 Pt 2","key":"R44-20250328","first-page":"219S","article-title":"Unconjugated bilirubin and cholesterol gallstone formation.","volume":"12","author":"Ostrow","year":"1990","journal-title":"Hepatology (Baltimore, Md)"},{"key":"R45-20250328","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1053\/j.gastro.2010.09.003","article-title":"Loci from a genome-wide analysis of bilirubin levels are associated with gallstone risk and composition.","volume":"139","author":"Buch","year":"2010","journal-title":"Gastroenterology"},{"key":"R46-20250328","doi-asserted-by":"crossref","first-page":"1178486","DOI":"10.3389\/fendo.2023.1178486","article-title":"Causal association between serum total bilirubin and cholelithiasis: a bidirectional two-sample Mendelian randomization study.","volume":"14","author":"Sun","year":"2023","journal-title":"Front Endocrinol"},{"key":"R47-20250328","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12876-023-02752-0","article-title":"Dietary fiber intake and risk of gallstone: a case-control study.","volume":"23","author":"Tehrani","year":"2023","journal-title":"BMC Gastroenterol"},{"key":"R48-20250328","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12929-023-00933-3","article-title":"Dietary diosgenin transcriptionally down-regulated intestinal NPC1L1 expression to prevent cholesterol gallstone formation in mice.","volume":"30","author":"Shen","year":"2023","journal-title":"J Biomed Sci"},{"key":"R49-20250328","first-page":"CD012608","article-title":"Modified dietary fat intake for treatment of gallstone disease in people of any age.","volume":"2","author":"Madden","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"key":"R50-20250328","doi-asserted-by":"crossref","first-page":"155774","DOI":"10.1016\/j.metabol.2023.155774","article-title":"Inhibition of PCSK9 prevents and alleviates cholesterol gallstones through PPAR\u03b1-mediated CYP7A1 activation.","volume":"152","author":"Chen","year":"2024","journal-title":"Metab Clin Exp"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041745","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T19:47:45Z","timestamp":1743364065000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,7]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041745","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,7]]}}}